STL Volume 10 Number 3
Update on Drugs and Drugs News April 2005
Updates on: Clinical Phototherapy System ClearTouch™ Light Unit Assembly Adalimumab HUMIRA® Dalbavancin Vicuron MDX-010 Medarex Clindamycin Evoclin® Foam 1%
Twelve Technical Strategies to the Perfect Surgical Scar
Achieving an excellent surgical result while managing disease can be a daunting task when the basic surgical principles we were all taught have been lost to time and the perpetuation of poor surgical habits that were adopted from others. Here are strategies that can help to improve your scar outcomes.
Drug Treatments for Skin Disease Introduced in 2004
An overview and update of skin conditions and treatments introduced in 2004 including Clindamycin Foam 1% Evoclin® Connetics, Cefdinir Oral Suspension Omnicef®, Clindamycin Evoclin® Foam 1%, and other treatments.
Mycophenolate Mofetil: A Dermatologic Perspective
Introduced in the 1970s as a treatment for psoriasis, mycophenolic acid has since been reformulated as mycophenolate mofetil (MMF). With an improved side-effect profile and enhanced bioavailability, MMF is a promising drug for immune-mediated skin disease.
